Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

Babalola Faseru



Author of

  • +

    MS15 - How to Get Patients to Quit Smoking; Practical Implementation of Evidence-Based Cessation Practices (ID 78)

    • Event: WCLC 2019
    • Type: Mini Symposium
    • Track: Prevention and Tobacco Control
    • Presentations: 1
    • Now Available
    • +

      MS15.01 - The Importance of Cessation and “5as” as a Framework for Cessation (Now Available) (ID 3525)

      11:30 - 13:00  |  Presenting Author(s): Babalola Faseru

      • Abstract
      • Presentation
      • Slides

      Abstract

      Almost two-thirds of newly diagnosed cancer patients have used or currently use tobacco. Evidence shows that continuous use of tobacco after cancer diagnosis adversely affects treatment outcomes among cancer patients compared to their counterparts who stop using tobacco. These outcomes include recovery, quality of life and survivorship.

      According to the United States Department of Health and Human Services clinical practice guideline for treating tobacco use and dependence, 5As include 1) Ask about tobacco use at every visit to identify and document tobacco use status of every patient 2) Advise every tobacco user to stop using tobacco – the message must be clear, strong and personal 3) Assess readiness to quit - implement strategies to motivate those who are not ready with 5Rs [Relevance, Risks, Rewards, Roadblocks and Repetition] 4) Assist those who are ready quit - develop (a) a quit plan using the STAR method [Set a quit date, Tell friends, family and co-workers and ask for their support, Anticipate challenges to the quit attempt, Remove all tobacco products] (b) recommend smoking cessation medication as indicated, provide counseling support and supplemental materials including information about the quitline where available 5) Arrange follow-up for additional support to avoid relapse. The efficacy of the 5As brief intervention recommendations have been described in the clinical practice guidelines. For example, clinicians who work in a setting where tobacco use status are easily captured are three times more likely to provide tobacco treatment to their patients OR 3.1 95% CI (2.2-4.2); physician advice to patients who smoke increases the odds of quitting compared to no physician advice OR 1.3 95% CI (1.1-1.6); and a combination of counseling and medication outperforms counseling alone OR 1.7 95% CI (1.3 - 2.1). This brief smoking cessation intervention approach using the 5As framework is feasible and cost effective. However, gaps in smoking cessation knowledge and practices in cancer care persist and tobacco use treatment remain suboptimal.

      During this mini symposium, we will discuss the effectiveness of 5As at various settings, examine other adaptations such as 3As, ABC, ABCD, AAR and identify ways to overcome the multi-level challenges of implementing evidence-based tobacco dependence treatment during cancer care.

      References

      Karam-Hage M, Cinciripini PM, Gritz ER. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014;64(4):272-290.

      Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401–10.

      Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev 2014;23:3-9

      Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569

      Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update, Clinical Practice Guideline. Rockville, MD: U. S. Department of Health and Human Services. Public Health Service; 2008.

      Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR. Identifying targeted strategies to improve smoking cessation support for cancer patients. J Thorac Oncol 2015;10:1532-1537.

      Price SN, Studts JL, Hamann HA. Tobacco Use Assessment and Treatment in Cancer Patients: A Scoping Review of Oncology Care Clinician Adherence to Clinical Practice Guidelines in the U.S. The oncologist. 2019;24(2):229-238

      Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. 2013;8:543–548

      McRobbie H Bullen C Glover M et al. New Zealand smoking cessation guidelines. N Z Med J . 2008;121(1276):57–70

      Gould GS Bittoun R Clarke MJ . A pragmatic guide for smoking cessation counselling and the initiation of nicotine replacement therapy for pregnant Aboriginal and Torres Strait Islander smokers. J Smoking Cessation . 2015;10(2):96–105

      Vidrine JI Shete S Cao Y et al. Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med . 2013;173(6):458–464

      Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.